NOUVELLES FORMES POSOLOGIQUES D'ADMINISTRATION PAR VOIE ORALE A LIBERATION IMMEDIATE ET MODIFIEE DE TEBIPENEME PIVOXIL

• 收藏
• 分享

专利权人:

SPERO THERAPEUTICS; INC.

发明人:

JAIN, AKASH,LU, ENXIAN,LYU, SHAOQIONG,LI, SHOUFENG,KEUTZER, TIMOTHY,UTLEY, LUKE,FRACZKIEWICZ, GRAZYNA,MACWAN, JOYCE

申请号：

CA3045566

公开号：

CA3045566A1

申请日:

2017.12.15

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

Immediate and modified release oral dosage forms of tebipenem pivoxil including dosage form cores are provided. The dosage form core includes tebipenem pivoxil in free base or salt form, and excipients including a binder, a lubricant, optionally a diluent, and optional additional excipients. The weight to weight ratio of tebipenem pivoxil to the excipients in the dosage form core is from 30:60 to 60:30. The disclosure includes methods of treating bacterial infections including complicated urinary tract infections.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/